1. Cartilage extracellular matrix regeneration with 10-gingerol via KEAP1-NRF2-ARE axis for osteoarthritis therapy

Yibo Ma, Chenhao Sun, Zongyue Wang, Changjian Chen

국내기사 | Archives of pharmacal research. vol. 48 no. 11-12(Nov.-Dec. 2025), p. 1460-1481 | The Pharmaceutical Society of Korea | 2025. 11. 30 |

2. Salvianolic acid A enhances T[reg] accumulation via the RUNX1/CBFβ/FOXP3 axis as a neuroprotective immunomodulator in ischemic stroke

Jiayang Wu, Kui Liu, Jinqian Song, Lihua Huang, Jiahong Gao, Fei Li, Tao Pang

국내기사 | Archives of pharmacal research. vol. 48 no. 11-12(Nov.-Dec. 2025), p. 1399-1419 | The Pharmaceutical Society of Korea | 2025. 11. 30 |

3. Resveratrol ameliorates liver fibrosis by inhibiting ATF4 to regulate glutamine metabolism in hepatic stellate cells

Huiya Ying, Yixiao Wang, Dandan Zhu, Jun Xu, Xiangting Zhang, Hong Pan, Yuan Zeng, Xiao Wu, Weimin Cai, Ruoru Zhou, Ziqiang Xia, Fujun Yu

국내기사 | Archives of pharmacal research. vol. 48 no. 11-12(Nov.-Dec. 2025), p. 1420-1440 | The Pharmaceutical Society of Korea | 2025. 11. 30 |

4. Comparative analysis of LJ-4378 and tirzepatide in mouse models of obesity and weight regain

Heeseong Kim, Seung Woo Kim, Cheoljun Choi, SungUg Joo, Gibae Kim, Minjae Kim, Eunsuk Yang, Jangwon Lee, Sukjae Chung, Lak Shin Jeong, Yun-Hee Lee

국내기사 | Archives of pharmacal research. vol. 48 no. 11-12(Nov.-Dec. 2025), p. 1441-1459 | The Pharmaceutical Society of Korea | 2025. 11. 30 |

5. Advances and challenges of estrogen receptor-targeted agents in breast cancer

Jie Hu, Songyang Zhong, Huayu Sun, Jie Liu, Wentong Fang

국내기사 | Archives of pharmacal research. vol. 48 no. 11-12(Nov.-Dec. 2025), p. 1177-1223 | The Pharmaceutical Society of Korea | 2025. 11. 30 |

6. Constituents from Caragana jubata (Pall.) Poir. and their in vitro neuroprotective effects

Xiaohong Wang, Hailian Yuan, Siyi Wang, Liang Liu

국내기사 | Archives of pharmacal research. vol. 48 no. 11-12(Nov.-Dec. 2025), p. 1314-1327 | The Pharmaceutical Society of Korea | 2025. 11. 30 |

7. Resmetirom, the first FDA-approved drug for MASH : from drug discovery and action mechanisms to clinical trials

Jiaman Liu, Fenghua Yang, Boya Gao, Lihui Yang, Yutong Cao, Yun Zhou

국내기사 | Archives of pharmacal research. vol. 48 no. 11-12(Nov.-Dec. 2025), p. 1299-1313 | The Pharmaceutical Society of Korea | 2025. 11. 30 |

8. Pharmacological targeting of HDAC/BET pathway enhances 5-FU efficacy in esophageal squamous cancer cells

Xiaqing Xu, Qian Liu, Feifei Yang, Yiqing Zhang, Wanruo Yuan, Wenfang Gao, Liying Ma, Qi Zhang

국내기사 | Archives of pharmacal research. vol. 48 no. 11-12(Nov.-Dec. 2025), p. 1362-1381 | The Pharmaceutical Society of Korea | 2025. 11. 30 |

9. Site-selective addition of succinimide motif through nitro-assisted C–H functionalization of (hetero) arenes under rhodium catalysis

Amitava Rakshit, Dabeen Lim, Jiheun Hyun, Pargat Singh, Neeraj Kumar Mishra, Jung Su Park, In Su Kim

국내기사 | Archives of pharmacal research. vol. 48 no. 11-12(Nov.-Dec. 2025), p. 1328-1344 | The Pharmaceutical Society of Korea | 2025. 11. 30 |

10. Exploring the roles of cytochrome P450 enzymes and their inhibitors in cancers and non-neoplastic human diseases

Hyein Lee, Yeo-Jung Kwon, Young-Jin Chun

국내기사 | Archives of pharmacal research. vol. 48 no. 11-12(Nov.-Dec. 2025), p. 1224-1252 | The Pharmaceutical Society of Korea | 2025. 11. 30 |